Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Scott Ribich
Michael Thomenius
Date of Patent
October 17, 2023
Patent Application Number
16306182
Date Filed
June 1, 2017
Patent Citations
Patent Primary Examiner
CPC Code
Patent abstract
The disclosure provides a method for treating cancer in a subject in need thereof comprising administering to the subject: (a) a therapeutically effective amount of an EZH2 inhibitor and (b) a therapeutically effective amount of an immune checkpoint inhibitor. In certain embodiments of the methods of the disclosure, the EZH2 inhibitor is tazemetostat.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.